1. Home
  2. SQNS vs SPRO Comparison

SQNS vs SPRO Comparison

Compare SQNS & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

SELL

Current Price

$2.23

Market Cap

38.0M

Sector

Technology

ML Signal

SELL

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

SELL

Current Price

$0.94

Market Cap

67.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SQNS
SPRO
Founded
2003
2013
Country
France
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.0M
67.0M
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
SQNS
SPRO
Price
$2.23
$0.94
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
★ $9.33
$5.33
AVG Volume (30 Days)
54.0K
★ 320.0K
Earning Date
11-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 111.81
EPS
★ N/A
N/A
Revenue
N/A
★ $66,802,000.00
Revenue This Year
$24.60
N/A
Revenue Next Year
$68.32
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 39.24
52 Week Low
$2.31
$0.95
52 Week High
$6.98
$3.08

Technical Indicators

Market Signals
Indicator
SQNS
SPRO
Relative Strength Index (RSI) 35.31 35.55
Support Level N/A N/A
Resistance Level $3.15 $1.27
Average True Range (ATR) 0.18 0.06
MACD -0.02 -0.01
Stochastic Oscillator 0.00 17.83

Price Performance

Historical Comparison
SQNS
SPRO

About SQNS Sequans Communications S.A.

Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: